In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis (COLRAS)

October 7, 2024 updated by: Aesculap AG

International, Prospective, Longterm Study Comparing the Clinical Outcome and In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis

This clinical study is a Post-Market Clinical Follow-Up (PMCF) measure and is aiming to compare the in-vivo wear behaviour of the Columbus® total knee prosthesis between the standard Cobalt Chromium (CoCr) and the multilayer coated so called "Advanced Surface" (AS) of the same implant. The clinical investigation is designed as a International, prospective, longterm non-interventional study in order to gain clinical data of many patients within the routine clinical application of the investigational device.

Study Overview

Study Type

Observational

Enrollment (Actual)

7

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Württemberg
      • Freiburg, Baden-Württemberg, Germany, 79106
        • Universitätsklinik Freiburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients will be recruited consecutively.

Description

Inclusion Criteria:

  • Indication for a primary bicondylar total knee endoprosthesis with the Columbus® DD knee prosthesis
  • Written signed informed consent of patient
  • Willingness and mental ability to participate at the long-term follow-up examinations

Exclusion Criteria:

  • Pregnancy
  • Patient age <45 and >75years
  • Acute inflammatory arthritis
  • Coagulation disorders (e.g. Haemophilia)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Columbus® DD Primary CoCr
Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr)
Total Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living
Other Names:
  • Columbus® Total Knee Arthroplasty
Columbus® DD Primary CoCr AS coated
Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) Advanced Surface
Total Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living
Other Names:
  • Columbus® Total Knee Arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Polyethylene wear over time
Time Frame: until 10 years postoperatively
The in-vivo wear of the Polyethylene (PE) tibial tray will be assessed using the observer independent method of the imaging core lab. The PE wear assessment is based on the absolute object position of the knee prosthesis over time.
until 10 years postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant survival
Time Frame: until 10 years postoperatively
Kaplan-Meier Analysis is a standard statistical method to describe the survival of human subjects or medical products over a defined time period.
until 10 years postoperatively
Quality of Life [EQ-5D-5L] compared to baseline
Time Frame: preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively

The 5-dimension 5-level measure of the health status, developed by the EuroQol Group (EQ-5D-5L) is a simple and generic measure for clinical and economic assessment. Instructions for the user are directly included into the questionnaire and it consists of two pages. One cover five different dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and the other one the EQ visual Analogue Scale (EQ-VAS). The VAS scale records the self rated health status of the patient from the level "the worst health you can imagine" to "the best health you can imagine".

The answer of each of the five dimensions result in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Progress of Clinical Outcome (Forgotten Joint Score-12) over follow-up period
Time Frame: 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
The Forgotten Joint Score-12 (FJS-12) Knee was designed to assess patient outcome in patients undergoing conservative or operative treatment of the knee. These Patient Reported Outcome (PRO) questionnaires focus on patients' awareness of a specific joint in everyday life. In 12 Items the awareness for the artificial joint is assessed by the patient, each on a five point scale (Never / Almost Never / Seldom / Sometimes / Mostly) The Forgotten Joint Score assessment consists of 12 questions and is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities
3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Progress of Clinical Outcome [Oxford Knee Score] compared to baseline
Time Frame: preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
The Oxford Knee Score (OKS) is a reliable 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing total knee replacement. It is short, reproducible, valid and sensitive to clinically important changes over time. Each of the 12 questions on the OKS is scored in the same way with the score decreasing as the reported symptoms increase (i.e. become worse). All questions are laid out with response categories denoting least (or no) symptoms to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0), as detailed for question 1 below. This method, when summed, produces overall scores running from 0 to 48 with 48 being the best outcome,
preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Radiographic comparison of alignment over time
Time Frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. The radiographic evaluation of Alignment combines Hip-Knee-Angle, femoral and tibial component alignment
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of implant migration over time
Time Frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. The radiographic evaluation of implant migration comprises tibial and femoral components in m/l and a/p direction,
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of tibial slope over time
Time Frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. Any changes of Tibial slope over the follow-up period is documented in the radiographic evaluation
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of the joint line over time
Time Frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. Any changes of the joint line over the follow-up period is documented in the radiographic evaluation
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Adverse events / serious adverse events
Time Frame: During the course of the study up to 10 years postoperatively
During the course of the study, any upcoming intra- or postoperative (serious) adverse events (AE / SAE) or device effects related or not related to the product under investigation or the procedure, will be documented in the dedicated Case Report Forms. The total number of AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product
During the course of the study up to 10 years postoperatively
Number of Participants with radiological complications over time
Time Frame: During the course of the study up to 10 years postoperatively

Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine.

All radiologically evident complications (including fracture, wear, loosening or radiolucencies) are cumulatively documented over the period of follow-up.

During the course of the study up to 10 years postoperatively
Biomechanical analysis of retrievals in case of revision
Time Frame: During the course of the study up to 10 years postoperatively
Available retrievals of explanted investigational products will be analysed by the biomechanical laboratory of the sponsor according to an analysis protocol which includes the oxidation profile, the wear behaviour, the mechanics and the cumulative linear abrasion of these retrievals.
During the course of the study up to 10 years postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline data
Time Frame: preoperatively
Demographics and medical history
preoperatively
Implant specifications
Time Frame: intraoperatively
The size and material of each component (tibial and femoral implant, liners, patella resurfacing) of the used implant are documented.
intraoperatively
Surgery time
Time Frame: intraoperatively
the Surgery time from first cut to wound closure is documented
intraoperatively
Axis Alignment data according to OrthoPilot® record
Time Frame: intraoperatively
The orthopaedic navigation system AESCULAP® OrthoPilot® Elite is based on 25 years of experience. During the navigated surgery a record with data on intraoperatively achieved alignment / joint line restoration is stored.
intraoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2023

Primary Completion (Actual)

February 1, 2024

Study Completion (Actual)

August 30, 2024

Study Registration Dates

First Submitted

August 11, 2022

First Submitted That Met QC Criteria

August 18, 2022

First Posted (Actual)

August 22, 2022

Study Record Updates

Last Update Posted (Estimated)

October 9, 2024

Last Update Submitted That Met QC Criteria

October 7, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on total knee prosthesis implantation

Subscribe